Cargando…
TGF-β Physiology as a Novel Therapeutic Target Regarding Autoimmune Thyroid Diseases: Where Do We Stand and What to Expect
Transforming growth factor beta (TGF-β), as a master regulator of immune response, is deeply implicated in the complex pathophysiology and development of autoimmune thyroid diseases. Based on the close interplay between thyroid autoimmunity and TGF-β, scientific interest was shifted to the understan...
Autores principales: | Kardalas, Efstratios, Maraka, Spyridoula, Papagianni, Maria, Paltoglou, George, Siristatidis, Charalampos, Mastorakos, George |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8232149/ https://www.ncbi.nlm.nih.gov/pubmed/34198624 http://dx.doi.org/10.3390/medicina57060621 |
Ejemplares similares
-
CHRONIC AUTOIMMUNE URTICARIA: WHERE WE STAND?
por: Goh, C L, et al.
Publicado: (2009) -
Autoimmune Myopathies: Where Do We Stand?
por: Simon, Jean-Philippe, et al.
Publicado: (2016) -
Neurogenic Erectile Dysfunction. Where Do We Stand?
por: Thomas, Charalampos, et al.
Publicado: (2021) -
The Current Evidence Regarding COVID-19 and Pregnancy: Where Are We Now and Where Should We Head to Next?
por: Kalampokas, Theodoros, et al.
Publicado: (2021) -
Subclinical Hypothyroidism in Women Planning Conception and During Pregnancy: Who Should Be Treated and How?
por: Maraka, Spyridoula, et al.
Publicado: (2018)